Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Generate Biomedicines, Inc.(GENB) | 62,673,117 | 62,673,117 | 0 | $783.41M | $1.06B | 68.66% | +$273.88M |
| Moderna, Inc.(MRNA) | 4,632,149 | 4,632,149 | 0 | $235.31M | $324.39M | 21.07% | +$89.08M |
| Sana Biotechnology, Inc.(SANA) | 25,001,856 | 25,001,856 | 0 | $72.01M | $87.26M | 5.67% | +$15.25M |
| Foghorn Therapeutics Inc.(FHTX) | 12,674,120 | 12,674,120 | 0 | $60.58M | $61.85M | 4.02% | +$1.27M |
| Seres Therapeutics, Inc.(MCRB) | 1,155,850 | 1,155,850 | 0 | $10.25M | $9.12M | 0.59% | -$1.13M |